SukeshCBurjonroppaMDFACC FSCAI

Cardiology • Fort Worth, TX

Adult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology

Physician

Join to view full profile

Dr. Burjonroppa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Burjonroppa's full profile

Already have an account?

Office
1900 Mistletoe Blvd
Suite 100
Fort Worth, TX 76104
Phone+1 817-333-8130
Is this information wrong?

Education & Training

University of California (San Francisco)Fellowship, Interventional Cardiology, 2007 - 2008
University of Texas Health Science Center at HoustonFellowship, Cardiovascular Disease, 2003 - 2006
Mercy Catholic Medical CenterResidency, Internal Medicine, 2000 - 2003
Bangalore Medical CollegeClass of 1998

Certifications & Licensure

CA State Medical License 2006 - Present
TX State Medical License 2008 - 2025
PA State Medical License 2001 - 2006
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Society of vascular medicine Endovascular specialist

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

9 citations
Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool.
Sukesh C. Burjonroppa, Paul D. Varosy, Sunil V. Rao, Fang Shu Ou, Matthew T. Roe, Eric D. Peterson, Mandeep Singh, Kendrick A. Shunk> ;JACC. Cardiovascular Interventions. 2011 Jan 1
8 citations
Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction.
Franca S. Angeli, Nicolas Amabile, Sukesh C Burjonroppa, Mia Shapiro, Lauren Bartlett, Yan Zhang, Renu Virmani, Kanu Chatterjee, Andrew J. Boyle, William Grossman, Yer...> ;Journal of Cardiac Failure. 2010 Jul 1
1 citations
Is it time to burst the "balloon" for high-risk patients?
Sukesh C Burjonroppa, Andrew J. Boyle, Yerem Yeghiazarians> ;The Journal of Invasive Cardiology. 2007 Aug 1
53 citations
Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload.
Sukesh C. Burjonroppa, Ann T. Tong, Lian Chun Xiao, Marcella M. Johnson, S. Wamique Yusuf, Daniel J. Lenihan> ;American Journal of Clinical Oncology. 2007 Jun 1
9 citations
Risk of Bleeding Complications Is Not Increased in Patients Undergoing Rescue versus Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Keith Ellis, Fernando Boccalandro, Sukesh Burjonroppa, Andreas Muench, Gregory M. Giesler, Richard W. Smalling, Stefano Sdringola> ;Journal of Interventional Cardiology. 2005 Oct 1
1 citations
Right atrial mass: primary angiosarcoma
S. C. Burjonroppa, Michael J. Reardon, J. Swafford> ;Heart. 2005 Oct 1
1 citations
Added accuracy with 3D echocardiographic imaging of valvular vegetations.
Malek El Muayed, Sukesh C. Burjonroppa, Mihai M. Croitoru> ;Echocardiography. 2005 Apr 1
5 citations
The use of brachytherapy to treat renal artery in-stent restenosis.
Keith Ellis, Blaithnead Murtagh, Catalin Loghin, Andreas Muench, Fernando Boccalandro, Brian Go, Muhammad Ahmad, Sukesh C. Burjonroppa, Oscar Rosales, Richard W. Smalling> ;Journal of Interventional Cardiology. 2005 Feb 1
Join now to see all